CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, X.
Right arrow Articles by Zuckerman, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, X.
Right arrow Articles by Zuckerman, K. S.
Cell Growth & Differentiation Vol. 11, 191-200, April 2000
© 2000 American Association for Cancer Research

Articles

Prolonged Activation of the Mitogen-activated Protein Kinase Pathway Is Required for Macrophage-like Differentiation of a Human Myeloid Leukemic Cell Line1

Xiaotang Hu2, Lynn C. Moscinski, Nikola I. Valkov, Ariana B. Fisher, Bobbye J. Hill and Kenneth S. Zuckerman

Division of Medical Oncology and Hematology, Departments of Internal Medicine [X. H., A. B. F., K. S. Z.], Biochemistry and Molecular Biology [K. S. Z.], and Pathology [L. C. M., N. I. V., B. J. H.], University of South Florida, and H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612

Abstract

The role of the mitogen-activated protein kinase (MAPK) signal transduction pathway in the proliferation of mammalian cells has been well established. However, there are relatively few reports concerning cell differentiation being mediated by MAPK. The effect of phorbol 12-myristate 13-acetate (PMA) on cell differentiation and signal transduction in a human myeloid leukemia cell line, TF-1a, was investigated. When TF-1a cells were treated with 10-6, 10-7, 10-8, and 10-9 M PMA for 24 h, they underwent 98, 93, 91, and 51% macrophage-like differentiation, respectively. PMA treatment rapidly (10 min) induced phosphorylation of MAPK kinase (MEK and p44/42 MAPK), which persisted for at least 24 h. p44/42 MAPK immunoprecipitates from lysates of PMA-treated cells had increased ability to phosphorylate the transcription factor Elk-1. This is important because phosphorylated Elk-1 can be considered an "end-product" of the MAPK pathway. In contrast, treatment of TF-1a cells with granulocyte/macrophage-colony stimulating factor induced only transient activation of MEK and p44/42 MAPK (10–20 min) and an increase (~50%) in cell proliferation, without any change in cellular differentiation. These results suggest that macrophage-like differentiation may be dependent on prolonged activation of the MAPK pathway. Additional support for this conclusion was obtained from experiments showing that treatment of TF-1a cells with antisense oligonucleotides for MEK1 coding sequences prior to adding PMA inhibited macrophage-like differentiation. Furthermore, transient transfection with an inactive, dominant-negative MEK mutant also inhibited PMA-induced differentiation, whereas transient transfection with a plasmid coding for constitutively activated MEK led to macrophage-like differentiation in the absence of PMA.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
M. C. Carreras and J. J. Poderoso
Mitochondrial nitric oxide in the signaling of cell integrated responses
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1569 - C1580.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M.-Y. Lee, W.-J. Kim, Y.-J. Kang, Y.-M. Jung, Y.-M. Kang, K. Suk, J.-E. Park, E.-M. Choi, B.-K. Choi, B. S. Kwon, et al.
Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis
J. Leukoc. Biol., October 1, 2006; 80(4): 922 - 928.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. C. Seales, F. M. Shaikh, A. V. Woodard-Grice, P. Aggarwal, A. C. McBrayer, K. M. Hennessy, and S. L. Bellis
A Protein Kinase C/Ras/ERK Signaling Pathway Activates Myeloid Fibronectin Receptors by Altering {beta}1 Integrin Sialylation
J. Biol. Chem., November 11, 2005; 280(45): 37610 - 37615.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Agassandian, J. Zhou, L. A. Tephly, A. J. Ryan, A. B. Carter, and R. K. Mallampalli
Oxysterols Inhibit Phosphatidylcholine Synthesis via ERK Docking and Phosphorylation of CTP:Phosphocholine Cytidylyltransferase
J. Biol. Chem., June 3, 2005; 280(22): 21577 - 21587.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Castelli, M. Camps, C. Gillieron, D. Leroy, S. Arkinstall, C. Rommel, and A. Nichols
MAP Kinase Phosphatase 3 (MKP3) Interacts with and Is Phosphorylated by Protein Kinase CK2{alpha}
J. Biol. Chem., October 22, 2004; 279(43): 44731 - 44739.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. M. Rosenberger and B. B. Finlay
Macrophages Inhibit Salmonella Typhimurium Replication through MEK/ERK Kinase and Phagocyte NADPH Oxidase Activities
J. Biol. Chem., May 17, 2002; 277(21): 18753 - 18762.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Jiang, Y. Jia, and I. Cohen
Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation
Blood, May 15, 2002; 99(10): 3579 - 3584.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. A. Barber, L. Bruett, B. R. Douglass, D. S. Herbst, M. C. Zink, and J. E. Clements
Visna Virus-Induced Activation of MAPK Is Required for Virus Replication and Correlates with Virus-Induced Neuropathology
J. Virol., January 15, 2002; 76(2): 817 - 828.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Krisanaprakornkit, J. R. Kimball, and B. A. Dale
Regulation of Human {beta}-Defensin-2 in Gingival Epithelial Cells: The Involvement of Mitogen-Activated Protein Kinase Pathways, But Not the NF-{kappa}B Transcription Factor Family
J. Immunol., January 1, 2002; 168(1): 316 - 324.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
N. R. Wall, R. M. Mohammad, and A. M. Al-Katib
Mitogen-activated Protein Kinase Is Required for Bryostatin 1-induced Differentiation of the Human Acute Lymphoblastic Leukemia Cell Line Reh
Cell Growth Differ., December 1, 2001; 12(12): 641 - 647.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Hu, W. E. Janssen, L. C. Moscinski, M. Bryington, A. Dangsupa, N. Rezai-Zadeh, B. A. Babbin, and K. S. Zuckerman
An I{kappa}B{alpha} Inhibitor Causes Leukemia Cell Death through a p38 MAP Kinase-dependent, NF-{kappa}B-independent Mechanism
Cancer Res., August 1, 2001; 61(16): 6290 - 6296.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. M. Krishna Rao
MAP kinase activation in macrophages
J. Leukoc. Biol., January 1, 2001; 69(1): 3 - 10.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C.-C. Liang and H.-C. Chen
Sustained Activation of Extracellular Signal-regulated Kinase Stimulated by Hepatocyte Growth Factor Leads to Integrin alpha 2 Expression That Is Involved in Cell Scattering
J. Biol. Chem., June 8, 2001; 276(24): 21146 - 21152.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2000 by the American Association of Cancer Research.